These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25251955)

  • 21. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stone formation and urine composition in calcium stone formers without medical treatment.
    Bek-Jensen H; Tiselius HG
    Eur Urol; 1989; 16(2):144-50. PubMed ID: 2714332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in 24-hour urine composition between apatite and brushite stone formers.
    Moreira DM; Friedlander JI; Hartman C; Elsamra SE; Smith AD; Okeke Z
    Urology; 2013 Oct; 82(4):768-72. PubMed ID: 23791217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Similarity of urinary risk factors among stone-forming patients in five regions of the United States.
    Harvey JA; Hill KD; Pak CY
    J Lithotr Stone Dis; 1990 Apr; 2(2):124-32. PubMed ID: 11536931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for biochemical abnormalities in urolithiasis patients.
    Orakzai N; Hanbury DC; Farrington K
    J Ayub Med Coll Abbottabad; 2004; 16(2):60-3. PubMed ID: 15455621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence.
    Lee SC; Kim YJ; Kim TH; Yun SJ; Lee NK; Kim WJ
    J Urol; 2008 Feb; 179(2):570-4. PubMed ID: 18078957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary metabolic evaluations in solitary and recurrent stone forming children.
    DeFoor W; Minevich E; Jackson E; Reddy P; Clark C; Sheldon C; Asplin J
    J Urol; 2008 Jun; 179(6):2369-72. PubMed ID: 18433777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M; Anders D; Graef V; Bödeker RH
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twenty four hours urine and serum biochemical parameters in patients with urolithiasis.
    Jawalekar S; Surve VT; Bhutey AK
    Nepal Med Coll J; 2010 Mar; 12(1):5-7. PubMed ID: 20677601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children.
    Milosević D; Batinić D; Konjevoda P; Blau N; Stambuk N; Nizić L; Vrljicak K; Batinić D
    J Chem Inf Comput Sci; 2003; 43(6):1844-7. PubMed ID: 14632431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
    J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary excretion of calcium, magnesium, phosphate, citrate, oxalate, and uric acid by healthy schoolchildren using a 12-h collection protocol.
    Hoppe B
    Pediatr Nephrol; 2014 Nov; 29(11):2065-7. PubMed ID: 25173356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
    Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
    Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective analysis of the metabolic status of stone formers in the New York City metropolitan areas.
    Hatch M; Schepers A; Grunberger I; Godec CJ
    N Y State J Med; 1991 May; 91(5):196-200. PubMed ID: 1857571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors in calcium stone disease of the urinary tract.
    Robertson WG; Peacock M; Heyburn PJ; Marshall DH; Clark PB
    Br J Urol; 1978 Dec; 50(7):449-54. PubMed ID: 37975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Ramadan fasting on urinary risk factors for calculus formation.
    Miladipour AH; Shakhssalim N; Parvin M; Azadvari M
    Iran J Kidney Dis; 2012 Jan; 6(1):33-8. PubMed ID: 22218117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertriglyceridemia is associated with increased risk for stone recurrence in patients with urolithiasis.
    Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Kim WJ
    Urology; 2014 Oct; 84(4):766-71. PubMed ID: 25106943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of body mass index on quantitative 24-h urine chemistries in stone forming patients: a systematic review and meta-analysis.
    Wang Q; Hu W; Lu Y; Hu H; Zhang J; Wang S
    Urolithiasis; 2018 Nov; 46(6):523-533. PubMed ID: 29423725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.